Additionally, high expression levels of peripheral Cldn1 and TGF-β and high serum levels of sCD163, IL-10, and IL-12 were significantly associated with the risk of HCC (P = 0.022–<0.0001). The gene discussed is CD163; the disease is hepatocellular carcinoma.